source
- Werewolf Therapeutics merges with Ambros in $150M deal to advance non‑opioid painkiller for rare limb injury syndromeWerewolf Therapeutics and Ambros Therapeutics announced a merger valued at $150 million, creating a new company that will retain the Ambros name. The deal includes a private placement to fund the…
- Early Alert: Epidural Kit Issue from Medical Action IndustriesMedical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.fda medwatch · 18h ago↗ source